May marks the recognition of National Brain Tumor Awareness Month. Since its establishment in 2008, community organizations and support groups honor this month with increased efforts to raise awareness of brain tumors, increase funding for research and educate the public on symptoms and treatment options.
The Central Brain Tumor Registry estimates 66,290 new cases of primary non–malignant and malignant brain and central nervous system tumors will be diagnosed in the United States in 2012.
“When researching treatment options, it’s important to know the right questions to ask,” explains Dr. Lori Coleman, medical director of San Diego Radiosurgery. “Patients should explore all treatment options and voice their concerns before deciding on which treatment is best for them.”
To learn more about brain tumors and Novalis Tx treatment, view our presentations here.
ExacTrac(r) Adaptive Gating Makes it Possible to Accurately Treat Tumors Affected By Respiration-Induced Movement.
San Diego Radiosurgery, a service of Palomar Medical Center in Escondido, California, is among the first in North America to treat a patient using the Novalis Tx(tm) radiosurgery platform with ExacTrac(r) Adaptive Gating. ExacTrac Adaptive Gating from BrainLAB addresses respiration induced tumor motion, allowing treatment only when the tumor is in the targeted position-ensuring precise dose delivery in order to protect nearby tissue and organs.
Local news coverage of Novalis Tx radiosurgery system at San Diego Radiosurgery.